Al-Tureihi, 200523
|
Case-control |
Yes |
Yes |
Age, and antibiotic treatment |
Aseeri et al, 200824
|
Case-control |
Yes |
Yes |
Admission date, sex, age group, antibiotic use, patient location, and room type |
Baxter et al, 200825
|
Case-control |
Yes |
Yes |
Number of days spent in the hospital, ICU days, antibiotics |
Barletta et al, 201326
|
Case-control |
Yes |
Yes |
Prior hospital admission, intensive care unit admission, admission from a skilled nursing facility, immunosuppression, number of antibiotics received, PPI duration, and time to event |
Beaulieu et al, 200727
|
Cohort |
Yes |
Yes |
Age, gender, length of stay, comorbidities, APACHE score, NGT feeding, tracheal tube placement, H2RA, and antibiotics |
Dalton et al, 200928
|
Cohort |
Yes |
Yes |
Independent covariates (demographics characteristics such as age, gender, race -ethnicity), albumin and white blood cell count at the time of CDAD diagnosis, the Charlson co-morbidity score, prior admissions to Montefiore Medical Center within 180 days, and prior use of antibiotics and PPIs. ( last two were dichotomous) |
Dubberke et al, 200729
|
Case-control |
Yes |
Yes |
Comorbid conditions that will increase the risk of CDAD (age, admissions, antibiotics, CDAD pressure, albumin level, leukemia/lymphoma, mechanical ventilations, H2RA, and anti-motility agents) |
Howell et al, 201030
|
Case-control |
Yes |
Yes |
Age, antibiotics, and propensity score-based likelihood of receipt of acid suppression therapy |
Jenkins et al, 201031
|
Case-control |
Yes |
Yes |
Not specified |
Kazakova et al, 200632
|
Case-control |
Yes |
Yes |
Antibiotics, H2RA, length of stay, COPD, psychosis, and depression |
Kim et al, 201033
|
Case-control |
Yes |
Yes |
Age, serum albumin level, and NGT feeding |
Linney et al, 201034
|
Case-control |
Yes |
Yes |
Age, sex, discharge date and hospital unit, antibiotics, IBD, cancer, diabetes, NGT feeding, LOS, and previous residence |
Loo et al, 200535
|
Case-control |
Yes |
Yes |
age, sex, number of days at risk for C. difficile associated diarrhea, Charlson index, and the use of chemotherapy, PPI, histamine H2 blockers and enteral feeding |
Manges et al, 201036
|
Case-control |
Yes |
Yes |
Controlled for Bacteroidetes, and Firmicutes spp. |
McFarland, 200737
|
Case-control |
Yes |
Yes |
Not specified |
Modena et al, 200538
|
Case-control |
Yes |
Yes |
Antibiotic use and infections |
Muto el al, 200539
|
Case-control |
Yes |
Yes |
Age, diabetes, organ transplantation, H2RA, and antibiotics |
Novack et al, 201440
|
Case-control |
Yes |
Yes |
Adjusting to Charlson index |
Pakyz et al, 201341
|
Case-control |
Yes |
Yes |
Controlling by patient level covariates NO hospital level medication covariates |
Shah et al, 200042
|
Case-control |
Yes |
Yes |
Not specified |
Stevens et al, 201143
|
Cohort |
Yes |
Yes |
Comorbid conditions within 48 hours following admission: diabetes, respiratory illness, kidney disease, transplant, and cancer. |
Yip et al, 200144
|
Case-control |
Yes |
Yes |
Not specified |
Wang et al, 201445
|
Cohort |
Yes |
Yes |
Not specified |